Intense immunohistochemical staining of SAA in brains of patients with neurologically confirmed AD and MS in comparison to an unaffected region and non-AD/MS brains has been reported, with the major site of SAA staining in both diseases being the myelin sheaths of axons in affected cortex25. This evidence concerns the gene SAA1 and myeloid sarcoma.